SOLARA ACTIVE PHARMA SCIENCES
Back to Balance Sheet
|
SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹191 Cr | ₹172 Cr | ₹217 Cr | ₹299 Cr | ₹206 Cr |
What is the latest Total Non-Current Liabilities ratio of SOLARA ACTIVE PHARMA SCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹191 Cr |
| Mar2024 | ₹172 Cr |
| Mar2023 | ₹217 Cr |
| Mar2022 | ₹299 Cr |
| Mar2021 | ₹206 Cr |
How is Total Non-Current Liabilities of SOLARA ACTIVE PHARMA SCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹191 Cr | 11.25 | |
| Mar2024 | ₹172 Cr | -21.00 | |
| Mar2023 | ₹217 Cr | -27.43 | |
| Mar2022 | ₹299 Cr | 44.93 | |
| Mar2021 | ₹206 Cr | - | |
Compare Total Non-Current Liabilities of peers of SOLARA ACTIVE PHARMA SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOLARA ACTIVE PHARMA SCIENCES | ₹2,205.4 Cr | -0.8% | -14.8% | -1.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,628.0 Cr | 3.5% | 5.6% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,975.0 Cr | -1.3% | 4.5% | 16.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,804.0 Cr | -0.7% | 6.9% | 47.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,829.0 Cr | 1.3% | 5.1% | 17.5% | Stock Analytics | |
| CIPLA | ₹106,768.0 Cr | -1.9% | -0.3% | -6% | Stock Analytics | |
SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOLARA ACTIVE PHARMA SCIENCES | -0.8% |
-14.8% |
-1.2% |
| SENSEX | -4.1% |
-5.8% |
5.8% |
You may also like the below Video Courses